Arovella Therapeutics Ltd. announced that Mr. Paul Hopper is stepping down from his role as Non-Executive Chairman on June 30, 2022. Non-Executive Director of Arovella, Dr Elizabeth Stoner will assume the role as interim Chairperson, while the company engages in a search for a replacement.
Arovella Therapeutics Ltd Announces Executive Changes
Published on 06/06/2022 at 07:25 pm EDT
S&P Capital IQ
Share
© S&P Capital IQ -
2022
Share
















